US loss of exclusivity · Oncology
Lynparza
AstraZeneca / Merck
2027
US generics from
2025
Today: 2026
2037
2025 worldwide sales
$3.3B
Date basis
Company guidance
US generics
Tentatively approved
Pharma Patent Cliff
by readouts.io
Data checked 24 October 2026 ·
Full Lynparza timeline →